Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$12.64
-0.18-1.4%
Last update: Oct 15, 8:39 AM
$12.36
-0.46-3.61%
Novavax Inc (NVAX) Stock Price, Quote, News & History
NVAXNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Novavax (NASDAQ:NVAX) through any online brokerage.
Other companies in Novavax’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Novavax has a consensus price target of $12.92.
The stock price for Novavax (NASDAQ: NVAX) is $12.3577 last updated October 15, 2026 at 8:39 AM EDT.
There are no upcoming dividends for Novavax.
Novavax does not have any upcoming earnings scheduled.
There is no upcoming split for Novavax.
Novavax is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
